Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetes.
Ontology highlight
ABSTRACT: A fundamental goal in understanding the mechanisms of autoimmune disease is the characterization of autoantigens that are targeted by autoreactive antibodies and T cells. Unfortunately, the identification of autoantigens is a difficult problem. We have begun to explore a novel route to the discovery of autoantibody/autoantigen pairs that involves comparative screening of combinatorial libraries of unnatural, synthetic molecules for compounds that bind antibodies present at much higher levels in the serum of individuals with a given autoimmune disease than in the serum of control individuals. We have shown that this approach can yield "antigen surrogates" capable of capturing disease-specific autoantibodies from serum. In this report, we demonstrate that the synthetic antigen surrogates can
SUBMITTER: Doran TM
PROVIDER: S-EPMC4339956 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA